Earn rewards for your opinion on lab products.

Get exclusive insights into life science trends.

Stay up to date on research news.

ISCT22: Orgenesis looks to simplify, lower costs of providing CGT therapies
May 9, 2022 -- Personalized cell and gene therapies (CGTs) offer the potential to address the most challenging diseases, Vered Caplan, CEO of biotech company Orgenesis, told ScienceBoard.net at the International Society for Cell & Gene Therapy (ISCT) 2022 annual meeting in San Francisco. However, several factors make CGTs complex, expensive, and difficult to bring to market, including small/personalized batch production and the fact that everything must be conducted in a very sterile environment. Read More
ISCT22: BroadOak’s Poltilove remains bullish on CGT market despite downturn
May 9, 2022 -- Bryan Poltilove, partner at BroadOak Capital Partners, spoke with ScienceBoard.net at the International Society for Cell & Gene Therapy (ISCT) 2022 annual meeting in San Francisco about how BroadOak’s medium- to long-term investment strategy sees “great science” happening in the sector that’s improving productivity and advancing cell and gene therapies (CGTs), biologics, and other modalities. Read More
ISCT22: Cell therapy has potential to address unmet medical needs in orthopedics
May 6, 2022 -- Miguel Forte, CEO of Bone Therapeutics, and president-elect of the International Society for Cell & Gene Therapy (ISCT), spoke with ScienceBoard.net at the ISCT 2022 annual meeting in San Francisco about regenerative medicine and orthopedics. Read More
ISCT working group weighs in on expanded access to CGT
May 6, 2022 -- Patricia Zettler, JD, associate professor of law at The Ohio State University, and chair of the International Society for Cell & Gene Therapy (ISCT) Expanded Access Working Group, spoke with ScienceBoard.net at the ISCT 2022 annual meeting in San Francisco about the regulatory and ethical issues around cell and gene therapy (CGT) expanded access. Read More
ISCT president calls for cell and gene therapy education, training amid ‘talent shortage’
May 6, 2022 -- This week in San Francisco, industry, investors, physicians, patients, and regulators convened at the International Society for Cell & Gene Therapy (ISCT) annual meeting. ISCT President Bruce Levine, PhD, professor of cancer gene therapy at the University of Pennsylvania, spoke with ScienceBoard.net at ISCT 2022 about the status and future of the field of cell and gene therapy. Read More
ISCT22: Tackling the ethical issues around cell and gene therapy
May 5, 2022 -- Unproven and unethical cell and gene therapies are a growing problem worldwide, according to Laertis Ikonomou, PhD, of the Department of Oral Biology at the University of Buffalo, and chair of the International Society for Cell & Gene Therapy (ISCT) Committee on the Ethics of Cell and Gene Therapy. Ikonomou spoke with ScienceBoard.net at the ISCT 2022 annual meeting in San Francisco this week. Read More
How has the COVID-19 pandemic affected pediatric care?
May 4, 2022 -- What impact has the COVID-19 pandemic had on the care of pediatric cancer patients internationally? It depends on the country, according to Dr. Muhammed Elhadi of the University of Tripoli in Libya. Elhadi spoke with ScienceBoard.net at the recent American Association for Cancer Research meeting in New Orleans. Read More
Manufacturing partnerships support high quality cell therapies
May 3, 2022 -- Chimeric Therapeutics, Ncardia, and Novartis are some of the companies that have decided to partner to make complex manufacturing processes more efficient for novel therapies, according to Cell and Gene Therapy Business Outlook, a sister publication of ScienceBoard. Read More
New pathology task force promoted at AACR
May 2, 2022 -- A pathology task force has been formed with the goal of promoting pathology's role in cancer research, according to Anil Parwani, PhD, professor of pathology at The Ohio State University. Parwani shed light on the new task force in an interview with ScienceBoard.net at the recent American Association for Cancer Research (AACR) meeting in New Orleans. Read More
CoVac-1 vaccine shows promise for immunocompromised patients
May 2, 2022 -- At the recent American Association for Cancer Research meeting in New Orleans, ScienceBoard.net spoke with the University of Tübingen’s Dr. Juliane Walz, professor of peptide-based immunotherapies, and research associate Claudia Tandler about the promising results their CoVac-1 vaccine has shown in immunocompromised patients. Read More
GVW and L7 discuss collaboration at Meeting on the Med
April 29, 2022 -- At the Cell & Gene Meeting on the Med in Barcelona, Spain, ScienceBoard.net spoke with Louis Hendriks, managing director at Global Value Web (GVW), and Vasu Rangadass, president and CEO at L7 Informatics, about the collaboration between the companies. Read More
Forge Biologics shares plans for growth at Meeting on the Med
April 29, 2022 -- Chief commercial officer John Maslowski and senior vice president of business development Magdalena Tyrpien of Forge Biologics spoke with ScienceBoard.net at the Cell & Gene Meeting on the Med in Barcelona, Spain, to discuss the return to live events and in-person collaboration, Forge's expansion, and how Forge's corporate culture and vision works for their growth. Read More
New mutational signatures pinpoint causes of cancer and personalize treatment
April 28, 2022 -- New research published on April 11 in Cancer Research has revealed a previously unknown mechanism in a common form of lung cancer that uses epigenetic regulation to avoid the effect of treatment. Read More
Mission Bio shares platform’s progress at Meeting on the Med
April 28, 2022 -- Mission Bio CEO Yan Zhang, PhD, and associate director of business development (cell and gene therapies) Nori Ueno spoke with ScienceBoard.net at the Cell & Gene Meeting on the Med in Barcelona, Spain, about the company's recent accomplishments with Tapestri, Mission Bio's single-cell platform for DNA analysis. Read More
Large-scale WGS of thousands of cancers find previously unreported mutational signatures
April 27, 2022 -- Large-scale whole-genome sequencing (WGS) of thousands of cancers has found previously unreported mutational signatures, including tumor-specific rare signatures, according to research published on April 21 in Science. Read More
Conferences
International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter
Latest Tweets